During the past decade, Beijing Hospital of the Ministry of Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Hospital of the Ministry of Health" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Beijing Hospital" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials sponsored and "Imunon" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Hospital of the Ministry of Health" #1 collaborator was "Beijing Chao Yang Hospital" with 1 trials as a collaborator, "Beijing Hospital of the Ministry of Health" with 1 trials as a collaborator, "China-Japan Friendship Hospital" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Guangxi Cancer Hospital" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Hospital of the Ministry of Health" are "Acute Lung Injury" (1 trials), "Benzodiazepine" (1 trials), "Breast Cancer" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetic Neuropathy, Painful" (1 trials). Many other conditions were trialed in "Beijing Hospital of the Ministry of Health" in a lesser frequency.

Most popular intervention types in "Beijing Hospital of the Ministry of Health" are "Drug" (7 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Hospital of the Ministry of Health" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beijing Hospital of the Ministry of Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Beijing Hospital of the Ministry of Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Hospital of the Ministry of Health, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".